Chemistry: molecular biology and microbiology – Vector – per se
Patent
1997-02-13
1999-06-29
Degen, Nancy
Chemistry: molecular biology and microbiology
Vector, per se
435325, 435334, 435371, 536 231, C12N 1563, C12N 1585, C07H 2104
Patent
active
059168030
ABSTRACT:
Target cell-specific, non-viral vectors for inserting genes into cells, pharmaceuticals composition comprising such vectors, and methods of their use. Target cell-specific, non-viral vectors for inserting at least one gene into cells of an organism, comprising a complex comprising the following components:
REFERENCES:
patent: 5169770 (1992-12-01), Chee et al.
patent: 5376543 (1994-12-01), Chee et al.
patent: 5460831 (1995-10-01), Kossovsky et al.
patent: 5578475 (1996-11-01), Jessee
Zhang et al, "Characterization of the Putative Fusogenic Domain in Vesicular Stomatitis Virus Glycoprotein G", J. of Virol., vol. 68, No. 4, Apr. 1994, pp. 2186-2193.
Sedmak et al, "Divergent Patterns of ELAM-1, ICAM-1, and VCAM-1 Expression on Cytomegalovirus-infected Endothelial Cells", Transplantation, vol. 58, No. 12, pp. 1379-1385.
Sedmak et al, "The role of interferon .beta. in human cytomegalovirus-mediated inhibition of HLS DR induction endothelial cells", Arch. Virol., 1995, pp. 111-126.
Schnittler et al, "Replication of Marburg Virus in Human Endothelial Cells", J. Clin. Invest., vol. 91, Apr. 1993. pp. 1301-1309.
Scheglovitova et al, "Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells", Arch. Virol., 1995, pp. 951-958.
Valentin et al, "Dual Tropism for Macrophages and Lymphocytes Is a Common Feature of Primary Human Immunodeficiency Virus Type 1 and 2 Isolates", J. of Virol., Oct. 1994, pp. 6684-6689.
Treichel et al, "The asialogylcoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers", J. Gen. Virol., 1994, pp. 3021-3029.
Thorogood, "The problems of building a head", Current Biology, 1993, vol. 3, No. 10, pp. 705-708.
Temonen et al, Effect of Interferon-.alpha. and Cell Differentiation of Puumala Virus Infection in Human Monocyte/Macrophages, Virol. 206, 1995, pp. 8-15.
Talarico et al, Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor, Proc. Natl. Acad. Sci. USA, vol. 87, Jun. 1990, pp. 4222-4225.
Szepanski et al, "A Single Point Mutation of the Influenza C Virus Glycoprotein (HEF) Changes the Viral Receptor-Binding Activity", Virol. 188, 1992, pp. 85-92.
Sugrue et al, "Structural Characteristics of the M2 Protein of Influenza A Viruses: Evidence That It Forms a Tetrameric Channel", Virol. 180, 1991, pp. 617-624.
Stickney et al, "Biologic response modifiers: therapeutic approaches to lymphoproliferative diseases", Current Opinion in Oncology, 1992, vol. 4, pp. 847-855.
Steinhauer et al, "Studies of the Membrane Fusion Activities of Fusion Peptide Mutants of Influenza Virus Hemagglutinin", J. of Virol, Nov. 1995, pp. 6643-6651.
Stegmann et al, "The HA2 Subunit of Influenza Hemagglutinin Inserts into the Target Membrane Prior to Fusion", J. of Biol. Chem., vol. 266, No. 27, pp. 18404-18410.
Speir et al, "Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis", Science, vol. 265, Jul. 15, 1994, p. 391-4.
Slingluff et al, "Direct analysis of tumor-associated peptide antigens", Current Opinion in Immunology, vol. 6, 1994, pp. 733-740.
Sharpless et al, Human Immunodeficiency Virus Type 1 Tropism for Brain Microglial Cells is Determined by a Region of the env Glycoprotein That Also Controls Macrophage Tropism, J. Virol. Apr. 1992, vol. 66, No. 4, pp. 2588-2593.
Sanger et al, "DNA sequencing with chain-terminating inhibitors", Proc. Natl. Acad. Sci. USA, vol. 74, No. 12, Dec. 1977, pp. 5463-5467.
Sanchez et al, "Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison withthe genome of Marburg virus", Virus Res., No. 29, 1993, pp. 215-240.
Rojanasakul et al, "Targeted Gene Delivery to Alveolar Macrophages via Fc Receptor-Mediated Endocytosis", Pharm. Res., vol. 11, No. 12, 1994, pp. 1731-1736.
Reichmann et al, "Reshaping human antibodies for therapy", Nature, vol. 332, Mar. 1988, pp. 323-327.
Printseva et al, "A 90-kd Surface Antigen from a Subpopulation of Smooth Muscle Cells from Human Atherosclerotic Lesions", Am. J. Pathol., vol. 134, No. 2, Feb. 1989, pp. 305-313.
Prince et al, "The Biology of Hepatitis C Virus Infection", Curr. Stud. Hematol. Blood Transf. Basel, Karger, No. 61, 1994, pp. 195-207.
Powelson et al, "Monoclonal Antibodies in Organ Transplantation", Biotech. Adv. vol. 11, 1993 pp. 725-740.
Pontisso et al, "the Role of PreS1 in the Interaction of Hepatitis B Virus with Human Hepatocytes", Hepatology, 1991, vol. 14, No. 2, p. 405-6.
Pleschka et al, "The catalytic triad of the influenza C virus glycoprotein HEF esterase: characterization by site-directed mutagenesis and functional analysis", J. Gen. Virol. vol. 76, 1995, pp. 2529-2537.
Plaeger-Marshall et al., "Replication of Herpes Simplex Virus in Blood Monocytes and Placental Macrophages from Human Neonates", Pediatric Research, vol. 26, No. 2, 1989, pp. 135-9.
Pinto et al, "Influenza Virus M.sub.2 Protein Has Ion Channel Activity", Cell, vol. 69, 1992, pp. 517-528.
Phalen et al, "Cholesterol Is Required for Infection byu Semliki Forest Virus", J. of Cell Biol., vol. 112, No. 4, 1991, pp. 615-623.
Persaud et al, Time Course and Cytokine Dependence of Human T-Cell Lymphotropic Virus Type 1 T-Lymphocyte Transformation as Revealed by a Microtiter Infectivity Assay, J. Virol., Oct. 1995, pp. 6297-6303.
Perales et al., An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes, Eur. J. Biochem., vol. 226, 1994, pp. 255-266.
Pensiero et al, Hantaan Virus Infection of Human Endothelial Cells, J. of Virol., vol. 66, No. 10, Oct. 1992, pp. 5929-5936.
Oshima et al, "Cloning, sequencing, and expression of cDNA for human .beta.-glucuronidase", Proc. Natl. Acad. Sci. USA, vol. 84, 1987, pp. 685-689.
Orazi et al, "Distinct morphophenotypic features of chronic B-cell leukaemias identified with CD1c and CD23 antibodies", Eur. J. Haemotol., 1991, vol. 47, pp. 28-35.
White, "Viral and Cellular Membrane Fusion Proteins", Annu. Rev. Physiol., vol. 52, pp. 675-97.
Wharton et al, "Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine", J. Gen. Virol., 75, 1994, pp. 945-8.
Waldmann et al, "The Interleukin-2 Receptor: A Target for Monoclonal Antibody Treatment of Human T-Cell Lymphotropic Virus I-Induced Adult T-Cell Leukemia", Blood, vol. 82, No. 6, Sep. 15, 1993, pp. 1701-12.
Waldmann et al, "In Vitro Induction of Endothelial Adhesion Molecule and MHC Antigen Expression by Cytomegalovirus-Activated CD4.sup.+ T Cells", Trans. Pro., vol. 27, No. 1, Feb. 1995, pp. 1269-71.
Volchkov et al, "GP mRNA of Ebola Virus Is Edited by the Ebola Virus Polymerase and by T7 and Vaccinia Virus Polymerases", Virol. 214, 1995.
Volchkov et al, "The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses", FEBS, vol. 305, No. 3, 1992, pp. 181-184.
Van Kooten et al, "Cytokines and Intracellular Signals Involved in the Regulation of B-CLL Proliferation", Leukemia and Lymphoma, 1993, vol. 12, pp. 27-33.
Maruyama et al, "Lipid composition is important for highly efficient target binding and retention of immunoliposomes", Proc. Natl. Acad. Sci. USA, Aug. 1990, vol. 87, pp. 5744-5748.
Martinez-Arends et al, "Activation of Human Tonsil Lymphocytes by Rabies Virus Nucleocapsid Superantigen", Clin. Imm. and Immunopath., vol. 77, No. 2, Nov. 1995, pp. 177-184.
Mannino et al, "Liposome Mediated Gene Transfer", Bio Techniques, vol. 6, No. 7, 1988, pp. 682-690.
Maeurer et al, "New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines", Mel. Res. 1996, vol. 6, pp. 11-24.
Lyles et al, "Dynamic Nature of the QuartenaryStructure of the Vesicular Stomatitis Virus Envelope Glycoprotein", Biochem. 1990, 29, 2442-9.
Lusso et al, "Infection of .gamma./.delta. T Lymphocytes by Human Herpesvirus 6: Transcriptional Induction of CD4 and Susceptibility to HIV Infection", J. of Exp. Med., vol. 181, Apr. 1995, pp. 1303-1310.
Luneberg et al, "Structure and
Kissel Thomas
Klenk Hans-Dieter
Muller Rolf
Sedlacek Hans-Harald
Degen Nancy
Hoechst Aktiengesellshaft
Wang Andrew
LandOfFree
Target cell-specific non-viral vectors for inserting genes into does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Target cell-specific non-viral vectors for inserting genes into , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Target cell-specific non-viral vectors for inserting genes into will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1375158